James Zou, PhD, assistant professor of biomedical information science at Stanford University, discusses machine studying and the alternative ways oncologists are using it for the administration, therapy, and prognosis of most cancers.Machine studying is being utilized in each early- and late-stage illness, and aids clinicians in offering the most effective therapy plans and choices for his or her sufferers with most cancers. In this video, Zou additional discusses a few of the particular strategies the algorithm is skilled to have a look at.Transcription:0:09 | Machine studying and synthetic intelligence are seeing a variety of functions in oncology. For instance, in prognosis, usually the clinicians are working with completely different sorts of imaging information may very well be mammography photos or CT scans. Machine studying AI algorithms may be very useful in serving to clinicians to investigate these sorts of photos for them to establish or to section related areas.0:39 | There are completely different phases the place machine studying is being utilized. They will go all the best way from early phases in prognosis to later phases in phrases of therapy planning and therapy suggestions. [On the] prognosis facet, we’re seeing a variety of these pc imaginative and prescient algorithms, which is a sort of AI or machine studying fashions which might be skilled to essentially perceive and analyze completely different photos. For instance, now there are algorithms which might be taking a look at histopathology photos and slides, and then attempt to diagnose and predict affected person outcomes based mostly on these histology photos.1:18 | There are additionally algorithms which might be skilled to have a look at mammography photos and attempt to detect tumors, legions from these mammography photos as different prognosis websites and different therapy planning websites. People additionally develop machine studying fashions that take a look at, for instance, mutation profiles of sufferers, proper from their somatic mutations, and then attempt to predict based mostly on these mutation profiles if immunotherapy or another remedies are prone to be therapy for this explicit affected person.
https://www.targetedonc.com/view/using-machine-learning-and-ai-in-oncology
Using Machine Learning and AI in Oncology
